Complete drug intelligence at three critical stages of the pharmaceutical lifecycle: R&D trials, Product launches, and Patent expiry.
Bringing together three of the most powerful IMS databases:
-
IMS LifeCycle R&D Focus - monitors over 26,000 drugs in R&D with over 9,700 drugs in active development, of which over 5,600 are biotechnology products
-
IMS LifeCycle New Product Focus - details launches of over 270,000 new products launched worldwide since 1982
-
IMS LifeCycle Patent Focus - evaluates 3,000 patent families with over 115,000 patent records with expiry and extension dates
Easy tracking of the life cycle of drugs:
-
Build up competitive profiles of companies and drugs affecting your market
-
Benchmark your product strategies against current market activities
-
Access licensing and joint venture opportunities in the context of comprehensive drug information
-
Identify new business opportunities with access to approximately 150,000 drug profiles
-
Analyze the market horizontally, e.g. by therapeutic class to: obtain a full picture of R&D activity and collaborations, identify the strengths and weaknesses of the patent protection, track the launch strategies drug companies have employed
More about this offering
Next Steps
